glp 1 thyroid cancer risk GLP-1RA and cancer: New study suggests detection bias, not causation Overscreening of patients on glucagon-like

As of May 2026, BPC-157 isnt FDA-approved and sits on the FDAs restricted (Category 2) compounding list, so selling it as a drug or supplement is illegal (source)

Horowitz M, Rayner CK, Marathe CS, Wu T, Jones KL (2020) Glucagon-like peptide-1 receptor agonists and the appropriate measurement of gastric emptying

It may interact adversely with zinc supplements as high zinc may induce metallothionein

Its a convenient, protein-packed start to the day that fits well within GLP-1 dietary goals

By increasing the effect of this hormone, GLP-1 weight loss medications improve glycemic control and help patients feel full after eating less

Bondanza, S